NCT07012759Recruiting
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
Novel Pleural Effusion Biomarkers Screening and Evaluation in Lung Adenocarcinoma Patients
Source: ClinicalTrials.gov · Last updated 5 Mar 2026
Brief summary (registry, in English)
This project aims to assess the expression levels of novel molecular markers identified through screening in clinical samples of malignant pleural effusion, to evaluate the feasibility and clinical utility of these markers as potential diagnostic genes for lung adenocarcinoma.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 1 Jun 2025
- Start date
- Jun 2025
- Primary completion date
- Dec 2026
- Lead sponsor
- Fu Jen Catholic University
- Diseases
- Lung cancer
- NCT number
- NCT07012759
What you commit to
- Study type: Observational
- Planned participants: 100
- From Jun 2025 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with malignancies other than lung adenocarcinoma.
Age
- Patients under the age of 18.
Who the study is looking for
- Patients requiring thoracentesis for pleural effusion drainage as determined by a physician based on clinical need.
- Signed informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fu Jen Catholic University Hospital, Fu Jen Catholic University Coordinator of this site? Confirm its status | New Taipei City | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.